Get startedLog in
    Picture of Laboratorios Farmaceuticos Rovi SA logo

    ROVI — Laboratorios Farmaceuticos Rovi SA Income Statement

    0.000.00%
    es flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Laboratorios Farmaceuticos Rovi SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue420649818830764
    Cost of Revenue
    Gross Profit241385520492478
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses345467562609584
    Operating Profit74.7181256220180
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes72.6183258220178
    Provision for Income Taxes
    Net Income After Taxes61.1153200170137
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income61.1153200170137
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income61.1153200170137
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS1.162.793.733.22.67
    Dividends per Share